4XUJ
Nucleosome core particle containing adducts from treatment with a thiomorpholine-substituted [(eta-6-p-cymene)Ru(3-hydroxy-2-pyridone)Cl] compound
Summary for 4XUJ
Entry DOI | 10.2210/pdb4xuj/pdb |
Descriptor | Histone H3.2, Histone H4, Histone H2A, ... (10 entities in total) |
Functional Keywords | nucleosome, ruthenium agent, dna-bindig protein-dna complex, dna-binding protein-dna complex, dna-binding protein/dna |
Biological source | Xenopus laevis (African clawed frog) More |
Cellular location | Nucleus: P84233 P62799 Q6AZJ8 P02281 |
Total number of polymer chains | 10 |
Total formula weight | 199153.51 |
Authors | Adhireksan, Z.,Davey, C.A. (deposition date: 2015-01-26, release date: 2016-01-27, Last modification date: 2025-08-20) |
Primary citation | Hanif, M.,Meier, S.M.,Adhireksan, Z.,Henke, H.,Martic, S.,Movassaghi, S.,Labib, M.,Kandioller, W.,Jamieson, S.M.F.,Hejl, M.,Jakupec, M.A.,Kraatz, H.B.,Davey, C.A.,Keppler, B.K.,Hartinger, C.G. Functionalization of Ruthenium(II)( eta 6 -p-cymene)(3-hydroxy-2-pyridone) Complexes with (Thio)Morpholine: Synthesis and Bioanalytical Studies. Chempluschem, 82:841-847, 2017 Cited by PubMed Abstract: Hydroxypyr(id)ones constitute an emerging platform for the design of drug molecules, owing to their favorable biocompatibility and toxicity profiles. Herein, [Ru (η -p-cymene)] complexes with 3-hydroxy-2-pyridinone functionalized with morpholine and thiomorpholine, as a means often used in medicinal chemistry to alter the physicochemical properties of drug compounds, are reported. The compounds underwent hydrolysis of the Ru-Cl bond and the aqua species were stable for up to 48 h in aqueous solution, as observed by H NMR spectroscopy and ESI-MS. The compounds formed adducts with amino acids and proteins through cleavage of the pyridinone ligand. Binding experiments to the nucleosome core particle by means of X-ray crystallography revealed similar reactivity and exclusive binding to histidine moieties of the histone proteins. Preliminary cyclin-dependent kinase 2 (CDK2)/cyclin A kinase inhibitory studies revealed promising activity similar to that of structurally related organometallic compounds. PubMed: 31961568DOI: 10.1002/cplu.201700050 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (3.18 Å) |
Structure validation
Download full validation report
